/KHRNF
KHRNF Stock - Khiron Life Sciences Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KHRNF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta5.70
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $12.79M | $8.02M | $9.58M | $891,677 | N/A |
| Gross Profit | $6.37M | $7.01M | $2.44M | $297,364 | N/A |
| Gross Margin | 49.8% | 87.4% | 25.4% | 33.3% | N/A |
| Operating Income | $-19,787,000 | $-23,604,989 | $-37,430,075 | $-19,896,333 | N/A |
| Net Income | $-33,129,000 | $-24,038,889 | $-36,377,779 | $-19,806,537 | N/A |
| Net Margin | -258.9% | -299.8% | -379.6% | -2221.3% | N/A |
| EPS | $-0.20 | $-0.20 | $-0.36 | $-0.41 | $-0.16 |
Company Overview
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
KHRNFBeat Rate
25%
Last 4 quarters
Avg Surprise
-286.3%
EPS vs Estimate
Beats / Misses
1/2
1 met exactly
Latest EPS
$-0.02
Q4 2022
EPS Surprise History
Q2 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q2 22
-1180.2%
$-0.09vs$0.01
Q2 22
-0.6%
$-0.02vs$-0.02
Q3 22
+35.6%
$-0.01vs$-0.02
Q4 22
0.0%
$-0.02vs$-0.02
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 26, 2025 | — | — | — | — |
Q3 2025 | Aug 9, 2025 | — | — | — | — |
Q3 2025 | Aug 1, 2025 | — | — | — | — |
Q3 2024 | Aug 26, 2024 | — | — | — | — |
Q2 2024 | May 28, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | — | — | — | — |
Q4 2023 | Oct 20, 2023 | — | — | — | — |
Q3 2023 | Sep 1, 2023 | — | — | — | — |
Q2 2023 | Jun 20, 2023 | $-0.01 | — | — | — |
Q2 2023 | Apr 19, 2023 | — | — | — | — |
Q4 2022 | Nov 30, 2022 | $-0.02 | $-0.02 | 0.0% | = MET |
Q3 2022 | Aug 26, 2022 | $-0.02 | $-0.01 | +35.6% | ✓ BEAT |
Q2 2022 | May 30, 2022 | $-0.02 | $-0.02 | -0.6% | ✗ MISS |
Q2 2022 | May 2, 2022 | $0.01 | $-0.09 | -1180.2% | ✗ MISS |
Q4 2021 | Nov 22, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.03 | — | — |
Q2 2021 | May 27, 2021 | — | $-0.03 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-0.01 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.04 | — | — |
Q3 2020 | Aug 24, 2020 | — | $-0.04 | — | — |
Latest News
Loading news...
Frequently Asked Questions about KHRNF
What is KHRNF's current stock price?
Khiron Life Sciences Corp. (KHRNF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for KHRNF?
No analyst price targets are currently available for this stock.
What sector is Khiron Life Sciences Corp. in?
Khiron Life Sciences Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is KHRNF's market cap?
Khiron Life Sciences Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does KHRNF pay dividends?
No, Khiron Life Sciences Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTCF
Aion Therapeutic Inc.
$0.00
Mkt Cap: $0.0B
BSPK
Bespoke Extracts, Inc.
$0.20
Mkt Cap: $0.0B
EVIO
EVIO, Inc.
$0.00
Mkt Cap: $0.0B
GENPF
Genix Pharmaceuticals Corporation
$0.03
Mkt Cap: $0.0B
HEMP
Hemp, Inc
$0.00
Mkt Cap: $0.0B
KAYS
Kaya Holdings, Inc.
$0.04
Mkt Cap: $0.0B
KOAN
Resonate Blends, Inc.
$0.00
Mkt Cap: $0.0B
LVRLF
CordovaCann Corp.
$0.03
Mkt Cap: $0.0B
PBFFF
Planet Based Foods Global Inc.
$0.05
Mkt Cap: $0.0B
SHMN
SOHM, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to KHRNF for comparison